Cargando…
Isobologram analysis of triple therapies
New concepts in radiation oncology are based on the concept that combinations of irradiation and molecular targeted drugs can yield synergistic or at least additive effects. Up to now the combination of two treatment modalities has been tested in almost all cases. Similar to conventional anti-cancer...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634864/ https://www.ncbi.nlm.nih.gov/pubmed/17044920 http://dx.doi.org/10.1186/1748-717X-1-39 |
_version_ | 1782130650445250560 |
---|---|
author | Niyazi, Maximilian Belka, Claus |
author_facet | Niyazi, Maximilian Belka, Claus |
author_sort | Niyazi, Maximilian |
collection | PubMed |
description | New concepts in radiation oncology are based on the concept that combinations of irradiation and molecular targeted drugs can yield synergistic or at least additive effects. Up to now the combination of two treatment modalities has been tested in almost all cases. Similar to conventional anti-cancer agents, the efficacy of targeted approaches is also subject to predefined resistance mechanisms. Therefore, it seems reasonable to speculate that a combination of more than two agents will ultimately increase the therapeutic gain. No tools for a bio-mathematical evaluation of a given degree of interaction for more than two anti-neoplastic agents are currently available. The present work introduces a new method for an evaluation of triple therapies and provides some graphical examples in order to visualize the results. |
format | Text |
id | pubmed-1634864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-16348642006-11-08 Isobologram analysis of triple therapies Niyazi, Maximilian Belka, Claus Radiat Oncol Methodology New concepts in radiation oncology are based on the concept that combinations of irradiation and molecular targeted drugs can yield synergistic or at least additive effects. Up to now the combination of two treatment modalities has been tested in almost all cases. Similar to conventional anti-cancer agents, the efficacy of targeted approaches is also subject to predefined resistance mechanisms. Therefore, it seems reasonable to speculate that a combination of more than two agents will ultimately increase the therapeutic gain. No tools for a bio-mathematical evaluation of a given degree of interaction for more than two anti-neoplastic agents are currently available. The present work introduces a new method for an evaluation of triple therapies and provides some graphical examples in order to visualize the results. BioMed Central 2006-10-17 /pmc/articles/PMC1634864/ /pubmed/17044920 http://dx.doi.org/10.1186/1748-717X-1-39 Text en Copyright © 2006 Niyazi and Belka; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Niyazi, Maximilian Belka, Claus Isobologram analysis of triple therapies |
title | Isobologram analysis of triple therapies |
title_full | Isobologram analysis of triple therapies |
title_fullStr | Isobologram analysis of triple therapies |
title_full_unstemmed | Isobologram analysis of triple therapies |
title_short | Isobologram analysis of triple therapies |
title_sort | isobologram analysis of triple therapies |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634864/ https://www.ncbi.nlm.nih.gov/pubmed/17044920 http://dx.doi.org/10.1186/1748-717X-1-39 |
work_keys_str_mv | AT niyazimaximilian isobologramanalysisoftripletherapies AT belkaclaus isobologramanalysisoftripletherapies |